• 企業・知財を促進
    • スタートアップ企業一覧
    • IP&技術一覧
  • ヘルプを取得
    • 質問を検索
    • プロジェクトを投稿
    • 専門家Directoryを検索
  • リソース
    • ドキュメントセンター
    • 特許を検索
    • 専門家の記事・ブログ
  • ニュース
    • Tech&IPニュース
  • マイアカウント
  • ログイン
  • 専門家向け

特許

68,018 件
全IP種別
PATENTFIELDで検索
IPを掲載
権利維持

TrnR2 receptor

GDNF family receptor alpha-2 (GFRα2), also known as the neurturin receptor, is a protein that in humans is encoded by the GFRA2 gene.[1][2] The GFRA2 protein is a glycosylphosphatidylinositol(GP...

権利維持

Persephin

Persephin is a neurotrophic factor in the glial cell line-derived neurotrophic factor (GDNF) family.

権利維持

Mammaglobin

Mammaglobin is a gene that encodes a 10-kilodalton glycoprotein.[1] In humans expression of the gene is limited to the adult mammary gland, a correlation between increased expression of the gene an...

権利維持

Secoisolariciresinol dehydr...

Secoisolariciresinol dehydrogenase (EC 1.1.1.331) is an enzyme with system name (-)-secoisolariciresinol:NAD+ oxidoreductase.[1][2][3] This enzyme catalyses the following chemical reaction (-)-s...

係属中

Dehydrodiconiferyl alcohol ...

Dehydrodiconiferyl alcohol benzylic ether reductase

権利維持

Desaturases

A fatty acid desaturase is an enzyme that removes two hydrogen atoms from a fatty acid, creating a carbon/carbon double bond. These desaturases are classified as delta - indicating that the doub...

権利維持

DXP reductoisomerase

DXP reductoisomerase (1-deoxy-D-xylulose 5-phosphate reductoisomerase or DXR) is an enzyme that interconverts 1-deoxy-D-xylulose 5-phosphate (DXP) and 2-C-methyl-D-erythritol 4-phosphate (MEP). It...

権利維持

Haemophilus influenzae

Haemophilus influenzae (formerly called Pfeiffer's bacillus or Bacillus influenzae) is a Gram-negative, coccobacillary, facultatively anaerobic bacterium belonging to the Pasteurellaceae family. H....

権利維持

Arterial stenosis

A stenosis (/stəˈnoʊsɨs/;[1][2] plural: stenoses, /stəˈnoʊˌsiːz/) (from Ancient Greek στένωσις, "narrowing") is an abnormal narrowing in a blood vessel or other tubular organ or structure. It is al...

権利維持

Atherosclerosis diagnosis

Areas of severe narrowing, stenosis, detectable by angiography, and to a lesser extent "stress testing" have long been the focus of human diagnostic techniques for cardiovascular disease, in genera...

権利維持

Atherosclerosis diagnosis

Areas of severe narrowing, stenosis, detectable by angiography, and to a lesser extent "stress testing" have long been the focus of human diagnostic techniques for cardiovascular disease, in genera...

権利維持

Annexin for cell imaging

In molecular biology, an annexin A5 affinity assay is a test to quantify the number of cells undergoing apoptosis. The assay uses the protein annexin A5 to tag apoptotic and dead cells, and the num...

権利維持

Amyloid

Amyloids are insoluble fibrous protein aggregates sharing specific structural traits. They arise from at least 18 inappropriately folded versions of proteins and polypeptides present naturally in t...

権利維持

Microdroplets

Microdroplets

権利維持

Nkx-6.1 gene

Homeobox protein Nkx-6.1 is a protein that in humans is encoded by the NKX6-1 gene. In the pancreas, NKX6.1 is required for the development of beta cells and is a potent bifunctional transcription...

係属中

Spectrophotometers

In chemistry, spectrophotometry is the quantitative measurement of the reflection or transmission properties of a material as a function of wavelength.[1] It is more specific than the general term ...

係属中

Apoptosis

Apoptosis (/ˌæpəˈtoʊsɪs/;[2][3] from Ancient Greek ἀπό apo, "by, from, of, since, than" and πτῶσις ptōsis, "fall") is the process of programmed cell death (PCD) that may occur in multicellular orga...

係属中

Increasing lignan content

Increasing lignan content

係属中

Angiotensin II

Angiotensin I is converted to angiotensin II (AII) through removal of two C-terminal residues by the enzyme angiotensin-converting enzyme (ACE), primarily through ACE within the lung (but also pres...

係属中

Persistent pain treatment

Chronic pain is defined as pain that has lasted longer than three to six months,[1][2] though some theorists and researchers have placed the transition from acute to chronic pain at 12 months.[3] O...

  • 最初
  • 前
  • …
  • 1224
  • 1225
  • 1226
  • 1227
  • 1228
  • 1229
  • 1230
  • 1231
  • 1232
  • …
  • 次
  • 最後
イノベーションと知的財産権のためのone-stop shop 今すぐ参加

IP Nexusについて

IP Nexusは、大学・研究機関と連携して新規技術の潜在的なビジネス価値を解明し、技術シーズ・スタートアップ企業を成功へと導かせ、投資家やその他のステークホルダーに貴重なリターンを生み出す知的財産(IP)の商業化企業です。テクノロジーとライフサイエンスにフォーカスしたハイポテンシャルな発明を早期に特定してコマーシャルディレクション、資金調達の専門知識およびマネジメント能力を提供します。アジア地域に特化した専門知識によりアジア地域にフォーカスしています。

免責事項

IP Nexusは、Ask an ExpertとService Marketplaceを提供しています。Ask an ExpertとService Marketplaceは、インタラクティブなオンラインサービスであり、迅速かつ容易にビジネスのための法的相談や法的サービスを見つけることができます。IP Nexusは、法律事務所ではなく、法的助言、法律家の斡旋などの法的サービスを提供することはなく、自ら法的代理を行うことはありません。

コンテンツ

  • 価格
  • よくある質問
  • 知的財産権(IP)の保護
  • 知的財産権(IP)の種類
  • 知的財産権(IP)に関する申し立て
  • 我々のチームについて
  • スタートアップ
  • お問い合せ
  • ブランド資産
  • 利用規約
  • プライバシーポリシー
  • PATENTFIELDで特許を検索

ニュースレター

購読

言語設定

© 2026 IP Nexus. All Rights Reserved.

レポート内容

      問い合わせフォーム